Abstract
T-type Ca2+ channels are a specific channel family controlling proliferation, differentiation, angiogenesis, and invasion of tumor cells. Molecular biology has identified three main subfamilies of α1 subunits, called Cav1, Cav2, and Cav3. The third subfamily contains three members, called T-types: Cav3.1 (α1G), Cav3.2 (α1H), and Cav3.3 (α1I). The Cav3 channels are expressed in normal tissues throughout the body as well as in different types of tumors such as breast, glioma/neuroblastomas, colorectal, gastric, hepatic and prostate tumors, T cell leukemia, retinoblastoma (RB), and phaeochromocytoma. It has been shown that increased functional expression of Cav3 channels plays a role in abnormal proliferation of tumor cells. In addition, a crosstalk between the Rho-ROCK pathway and Cav3 channels in tumor cell migration and invasion has been demonstrated. Cav3 expression is strictly regulated during cell differentiation and tumor formation. Inactivation of Cav3 genes by aberrant methylation plays a major role in tumor development and progression. In this regard, since hypermethylation of CpG islands is thought to be the major epigenetic modification repressing gene transcription, Cav3.1 has been regarded as a candidate tumor suppressor gene. In contrast, CpG sites in the Cav3.2 gene were hypomethylated, and thus this gene is considered to be a candidate oncogene, regulated by methylation. Finally, Cav3 functional diversity may also result from the generation of splice variants. Alterations in the expression of different splice variants, and their expression during tumor development and progression, may trigger variety in Ca2+ signaling, which may contribute to the generation of more aggressive tumor clones.
Keywords
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Abrahamsson PA (1999) Neuroendocrine differentiation in prostatic carcinoma. Prostate 39(2):135–148
Antequera F, Bird A (1993) Number of CpG islands and genes in human and mouse. Proc Natl Acad Sci USA 90(24):11995–11999
Antequera F, Boyes J, Bird A (1990) High levels of de novo methylation and altered chromatin structure at CpG islands in cell lines. Cell 62(3):503–514
Asaga S, Ueda M, Jinno H, Kikuchi K, Itano O, Ikeda T, Kitajima M (2006) Identification of a new breast cancer-related gene by restriction landmark genomic scanning. Anticancer Res 26(1A):35–42
Assandri R, Egger M, Gassmann M, Niggli E, Bauer C, Forster I, Gorlach A (1999) Erythropoietin modulates intracellular calcium in a human neuroblastoma cell line. J Physiol 516(Pt 2):343–352
Berridge MJ, Bootman MD, Lipp P (1998) Calcium - a life and death signal. Nature 395(6703):645–648
Bertolesi GE, Jollimore CA, Shi C, Elbaum L, Denovan-Wright EM, Barnes S, Kelly ME (2003) Regulation of alpha1G T-type calcium channel gene (CACNA1G) expression during neuronal differentiation. Eur J Neurosci 17(9):1802–1810
Bertolesi GE, Shi C, Elbaum L, Jollimore C, Rozenberg G, Barnes S, Kelly ME (2002) The Ca(2+) channel antagonists mibefradil and pimozide inhibit cell growth via different cytotoxic mechanisms. Mol Pharmacol 62(2):210–219
Bertolesi GE, Walia Da Silva R, Jollimore CA, Shi C, Barnes S, Kelly ME (2006) Ca(v)3.1 splice variant expression during neuronal differentiation of Y-79 retinoblastoma cells. Neuroscience 141(1):259–268
Blaheta RA, Hailer NP, Brude N, Wittig B, Oppermann E, Leckel K, Harder S, Scholz M, Weber S, Encke A, Markus BH (1998) Novel mode of action of the calcium antagonist mibefradil (Ro 40–5967): potent immunosuppression by inhibition of T-cell infiltration through allogeneic endothelium. Immunology 94(2):213–220
Bunn HF, Poyton RO (1996) Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76(3):839–885
Burchardt T, Burchardt M, Chen MW, Cao Y, de la Taille A, Shabsigh A, Hayek O, Dorai T, Buttyan R (1999) Transdifferentiation of prostate cancer cells to a neuroendocrine cell phenotype in vitro and in vivo. J Urol 162(5):1800–1805
Castro M, Grau L, Puerta P, Gimenez L, Venditti J, Quadrelli S, Sánchez-Carbayo M (2010) Multiplexed methylation profiles of tumor suppressor genes and clinical outcome in lung cancer. J Transl Med 8:86–97
Chemin J, Monteil A, Briquaire C, Richard S, Perez-Reyes E, Nargeot J, Lory P (2000) Overexpression of T-type calcium channels in HEK-293 cells increases intracellular calcium without affecting cellular proliferation. FEBS Lett 478(1–2):166–172
Chemin J, Monteil A, Dubel S, Nargeot J, Lory P (2001) The alpha1I T-type calcium channel exhibits faster gating properties when overexpressed in neuroblastoma/glioma NG 108-15 cells. Eur J Neurosci 14(10):1678–1686
Chemin J, Nargeot J, Lory P (2002) Neuronal T-type alpha 1H calcium channels induce neuritogenesis and expression of high-voltage-activated calcium channels in the NG108-15 cell line. J Neurosci 22(16):6856–6862
Chemin J, Nargeot J, Lory P (2004) Ca(v)3.2 calcium channels control an autocrine mechanism that promotes neuroblastoma cell differentiation. Neuroreport 15(4):671–675
De Smet C, De Backer O, Faraoni I, Lurquin C, Brasseur F, Boon T (1996) The activation of human gene MAGE-1 in tumor cells is correlated with genome-wide demethylation. Proc Natl Acad Sci U S A 93(14):7149–7153
Del Toro R, Levitsky KL, pez-Barneo JL, Chiara MD (2003) Induction of T-type Calcium Channel Gene Expression by Chronic Hypoxia. J Biol Chem 278(25):22316–22324
Díaz-Lezama N, Hernández-Elvira M, Sandoval A, Monroy A, Felix R, Monjaraz E (2010) Ghrelin inhibits proliferation and increases T-type Ca2+ channel expression in PC-3 human prostate carcinoma cells. Biochem Biophys Res Commun 403(1):24–29
Ehrlich M (2002) DNA methylation in cancer: too much, but also too little. Oncogene 21(35):5400–5413
Estacion M, Mordan LJ (1997) PDGF-stimulated calcium influx changes during in vitro cell transformation. Cell Signalling 9(5):363–366
Feinberg AP, Vogelstein B (1983) Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301(5895):89–92
Foster SA, Wong DJ, Barrett MT, Galloway DA (1998) Inactivation of p16 in human mammary epithelial cells by CpG island methylation. Mol Cell Biol 18(4):1793–1801
Gackière F, Bidaux G, Delcourt P, Van Coppenolle F, Katsogiannou M, Dewailly E, Bavencoffe A, Van Chuoï-Mariot MT, Mauroy B, Prevarskaya N, Mariot P (2008) Cav3.2 T-type calcium channels are involved in calcium-dependent secretion of neuroendocrine prostate cancer cells. J Biol Chem 283(15):10162–10173
Gallie BL, Campbell C, Devlin H, Duckett A, Squire JA (1999) Developmental basis of retinal-specific induction of cancer by RB mutation. Cancer Res 59(7 Suppl):1731s–1735s
Gaudet F, Hodgson JG, Eden A, Jackson-Grusby L, Dausman J, Gray JW, Leonhardt H, Jaenisch R (2003) Induction of tumors in mice by genomic hypomethylation. Science 300(5618):489–492
Giannone G, Ronde P, Gaire M, Haiech J, Takeda K (2002) Calcium oscillations trigger focal adhesion disassembly in human U87 astrocytoma cells. J Biol Chem 277(29):26364–26371
Gray LS, Perez-Reyes E, Gomora JC, Haverstick DM, Shattock M, McLatchie L, Harper J, Brooks G, Heady T, Macdonald TL (2004) The role of voltage gated T-type Ca2+ channel isoforms in mediating “capacitative” Ca2+ entry in cancer cells. Cell Calcium 36(6):489–497
Harkins AB, Cahill AL, Powers JF, Tischler AS, Fox AP (2003) Expression of recombinant calcium channels support secretion in a mouse pheochromocytoma cell line. J Neurophysiol 90(4):2325–2333
Harris AL (2002) Hypoxia—a key regulatory factor in tumour growth. Nat Rev Cancer 2(1):38–47
Haverstick DM, Heady TN, Macdonald TL, Gray LS (2000) Inhibition of human prostate cancer proliferation in vitro and in a mouse model by a compound synthesized to block Ca2+ entry. Cancer Res 60(4):1002–1008
Hawkins N, Norrie M, Cheong K, Mokany E, Ku SL, Meagher A, O’Connor T, Ward R (2002) CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122(5):1376–1387
Hirooka K, Bertolesi GE, Kelly ME, Denovan-Wright EM, Sun X, Hamid J, Zamponi GW, Juhasz AE, Haynes LW, Barnes S (2002) T-Type calcium channel alpha1G and alpha1H subunits in human retinoblastoma cells and their loss after differentiation. J Neurophysiol 88(1):196–205
Hofmann F, Lacinova L, Klugbauer N (1999) Voltage-dependent calcium channels: from structure to function. Rev Physiol Biochem Pharmacol 139:33–87
Huang JB, Kindzelskii AL, Clark AJ, Petty HR (2004) Identification of channels promoting calcium spikes and waves in HT1080 tumor cells: their apparent roles in cell motility and invasion. Cancer Res 64(7):2482–2489
Iftinca M, Hamid J, Chen L, Varela D, Tadayonnejad R, Altier C, Turner RW, Zamponi GW (2007) Regulation of T-type calcium channels by Rho-associated kinase. Nat Neurosci 10(7):854–860
Jass JR (2005) Serrated adenoma of the colorectum and the DNA-methylator phenotype. Nat Clin Pract Oncol 2(8):398–405
Kawasaki T, Ohnishi M, Nosho K, Suemoto Y, Kirkner GJ, Meyerhardt JA, Fuchs CS, Ogino S (2008) CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci. Mod Pathol 21(3):245–255
Klugbauer N, Marais E, Lacinova L, Hofmann F (1999) A T-type calcium channel from mouse brain. Pflugers Arch 437(5):710–715
Kuga T, Kobayashi S, Hirakawa Y, Kanaide H, Takeshita A (1996) Cell cycle–dependent expression of L- and T-type Ca2+ currents in rat aortic smooth muscle cells in primary culture. Circ Res 79(1):14–19
Kunert-Radek J, Stepien H, Radek A, Lyson K, Pawlikowski M (1989) Inhibitory effect of calcium channel blockers on proliferation of human glioma cells in vitro. Acta Neurol Scand 79(2):166–169
Latour I, Louw DF, Beedle AM, Hamid J, Sutherland GR, Zamponi GW (2004) Expression of T-type calcium channel splice variants in human glioma. Glia 48:112–119
Lesouhaitier O, Chiappe A, Rossier MF (2001) Aldosterone increases T-type calcium currents in human adrenocarcinoma (H295R) cells by inducing channel expression. Endocrinology 142(10):4320–4330
Leuranguer V, Bourinet E, Lory P, Nargeot J (1998) Antisense depletion of beta-subunits fails to affect T-type calcium channels properties in a neuroblastoma cell line. Neuropharmacology 37(6):701–708
Li W, Zhang SL, Wang N, Zhang BB, Li M (2011) Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. Cancer Invest 29(5):339–346
Li Y, Liu S, Lu F, Zhang T, Chen H, Wu S, Zhuang H (2009) A role of functional T-type Ca2+ channel in hepatocellular carcinoma cell proliferation. Oncol Rep 22(5):1229–1235
Lory P, Bidaud I, Chemin J (2006) T-type calcium channels in differentiation and proliferation. Cell Calcium 40(2):135–146
Lu F, Chen H, Zhou C, Liu S, Guo M, Chen P, Zhuang H, Xie D, Wu S (2008) T-type Ca2+ channel expression in human esophageal carcinomas: a functional role in proliferation. Cell Calcium 43(1):49–58
Mareel M, Leroy A (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83(2):337–376
Mariot P, Vanoverberghe K, Lalevee N, Rossier MF, Prevarskaya N (2002) Overexpression of an alpha 1H (Cav3.2) T-type calcium channel during neuroendocrine differentiation of human prostate cancer cells. J Biol Chem 277(13):10824–10833
Martin RL, Lee JH, Cribbs LL, Perez-Reyes E, Hanck DA (2000) mibefradil block of cloned T-type calcium channels. J Pharmacol Exp Ther 295(1):302–308
Melki JR, Vincent PC, Clark SJ (1999) Concurrent DNA hypermethylation of multiple genes in acute myeloid leukemia. Cancer Res 59(15):3730–3740
Mittman S, Guo J, Agnew WS (1999) Structure and alternative splicing of the gene encoding alpha1G, a human brain T calcium channel alpha1 subunit. Neurosci Lett 274(3):143–146
Monteil A, Chemin J, Leuranguer V, Altier C, Mennessier G, Bourinet E, Lory P, Nargeot J (2000) Specific properties of T-type calcium channels generated by the human alpha 1I subunit. J Biol Chem 275(22):16530–16535
Nebe B, Holzhausen C, Rychly J, Urbaszek W (2002) Impaired mechanisms of leukocyte adhesion in vitro by the calcium channel antagonist mibefradil. Cardiovasc Drugs Ther 16(3):183–193
Newsholme P, Adogu AA, Soos MA, Hales CN (1993) Complement induced Ca21 influx in cultured fibroblasts is decreased by the calcium-channel antagonist nifedipine or by some bivalent inorganic cations. Biochem J 295(Pt3):773–779
Ogino S, Kawasaki T, Kirkner GJ, Kraft P, Loda M, Fuchs CS (2007) Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample. J Mol Diagn 9(3):305–314
Ohkubo T, Yamazaki Y (2012) T-type voltage-activated calcium channel Cav3.1, but not Cav3.2, is involved in the inhibition of proliferation and apoptosis in MCF-7 human breast cancer cells. Int J Oncol 41(1):267–275
Panner A, Cribbs LL, Zainelli GM, Origitano TC, Singh S, Wurster RD (2005) Variation of T-type calcium channel protein expression affects cell division of cultured tumor cells. Cell Calcium 37(2):105–119
Panner A, Wurster RD (2006) T-type calcium channels and tumor proliferation. Cell Calcium 40(2):253–259
Park JY, Kang HW, Moon HJ, Huh SU, Jeong SW, Soldatov NM, Lee JH (2006) Activation of protein kinase C augments T-type Ca2+ channel activity without changing channel surface density. J Physiol 577(Pt 2):513–523
Perez-Reyes E (1999) Three for T: molecular analysis of the low voltage-activated calcium channel family. Cell Mol Life Sci 56(7–8):660–669
Razin A, Cedar H (1994) DNA methylation and genomic imprinting. Cell 77(4):473–476
Ronde P, Giannone G, Gerasymova I, Stoeckel H, Takeda K, Haiech J (2000) Mechanism of calcium oscillations in migrating human astrocytoma cells. Biochim Biophys Acta 1498(2–3):273–280
Santoni G, Santoni M, Nabissi M (2012) Functional role of T-type calcium channels in tumour growth and progression: prospective in cancer therapy. Br J Pharmacol 166(4):1244–1246
Schmutte C, Jones PA (1998) Involvement of DNA methylation in human carcinogenesis. Biol Chem 379(10):377–388
Shimizu T, Ohta Y, Ozawa H, Matsushima H, Takeda K (2000) Papaverine combined with prostaglandin E2 synergistically induces neuron-like morphological changes and decrease of malignancy in human prostatic cancer LNCaP cells. Anticancer Res 20(2A):761–767
Seigel GM (1999) The golden age of retinal cell culture. Mol Vis 5:4
Tang C, Presser F, Morad M (1988) Amiloride selectively blocks the low threshold (T) calcium channel. Science 240(4849):213–215
Taylor JT, Huang L, Pottle JE, Liu K, Yang Y, Zeng X, Keyser BM, Agrawal KC, Hansen JB, Li M (2008) Selective blockade of T-type Ca2+ channels suppresses human breast cancer cell proliferation. Cancer Lett 267(1):116–124
Taylor SC, Peers C (1999) Chronic hypoxia enhances the secretory response of rat phaeochromocytoma cells to acute hypoxia. J Physiol 514(Pt 2):483–491
Teodorczyk M, Martin-Villalba A (2009) Sensing Invasion: Cell Surface Receptors. Driving Spreading of Glioblastoma. J Cell Physiol 222(1):1–10
Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa J-PJ (1999a) CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96(15):8681–8686
Toyota M, Ahuja N, Suzuki H, Itoh F, Ohe-Toyota M, Imai K, Baylin SB, Issa JP (1999b) Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res 59(21):5438–5442
Toyota M, Ho C, Ohe-Toyota M, Baylin SB, Issa JP (1999c) Inactivation of CACNA1G, a T-type calcium channel gene, by aberrant methylation of its 5’ CpG island in human tumors. Cancer Res 59:4535–4541
Trump BF, Berezesky IK (1995) Calcium-mediated cell injury and cell death. FASEB J 9(2):219–228
Ueki T, Toyota M, Sohn T, Yeo CJ, Issa JP, Hruban RH, Goggins M (2000) Hypermethylation of multiple genes in pancreatic adenocarcinoma. Cancer Res 60(7):1835–1839
Ueki T, Walter KM, Skinner H, Jaffee E, Hruban RH, Goggins M (2002) Aberrant CpG island methylation in cancer cell lines arises in the primary cancers from which they were derived. Oncogene 21(13):2114–2117
Wang YQ, Brooks G, Zhu CB, Yuan WZ, Li YQ, Wu XS (2002) Functional analysis of the human T-type calcium channel alpha 1H subunit gene in cellular proliferation. Yi Chuan Xue Bao 29(8):659–665
Yoshida M, Nosaka K, Yasunaga J, Nishikata I, Morishita K, Matsuoka M (2004) Aberrant expression of the MEL1S gene identified in association with hypomethylation in adult T-cell leukemia cells. Blood 103(7):2753–2760
Yunker AM, Sharp AH, Sundarraj S, Ranganathan V, Copeland TD, McEnery MW (2003) Immunological characterization of T-type voltage-dependent calcium channel Cav3.1 (alpha 1G) and Cav3.3 (alpha 1I) isoforms reveal differences in their localization, expression, and neural development. Neuroscience 117(2):321–335
Zelivianski S, Verni M, Moore C, Kondrikov D, Taylor R, Lin MF (2001) Multipathways for transdifferentiation of human prostate cancer cells into neuroendocrine-like phenotype. Biochim Biophys Acta 1539(1–2):28–43
Zhang Y, Zhang J, Jiang D, Zhang D, Qian Z, Liu C, Tao J (2012) Inhibition of T-type Ca²+ channels by endostatin attenuates human glioblastoma cell proliferation and migration. Br J Pharmacol 166(4):1247–1260
Zhu WH, Conforti L, Czyzyk-Krzeska MF, Millhorn DE (1996) Membrane depolarization in PC-12 cells during hypoxia is regulated by an O2-sensitive K+ current. Am J Physiol 271(2 Pt 1):C658–C665
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Morelli, M.B. et al. (2014). Epigenetic, Genetic, and Acquired Regulation of Cav3 T-Type Calcium Channel Expression and Function in Tumor Growth and Progression. In: Weiss, N., Koschak, A. (eds) Pathologies of Calcium Channels. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-40282-1_15
Download citation
DOI: https://doi.org/10.1007/978-3-642-40282-1_15
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-40281-4
Online ISBN: 978-3-642-40282-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)